Brookfield Business Partners Drives New Growth Strategy
BROOKFIELD, NEWS — Brookfield Business Partners (NYSE: BBU, BBUC; TSX: BBU.UN, BBUC) has unveiled its latest move to strengthen its position within the private equity landscape with a significant transaction involving the sale of a partial interest in three distinct businesses. This strategic maneuver aims to provide immediate benefits, enabling Brookfield to cultivate a new evergreen private equity strategy.
Transaction Overview
The recent agreement entails that Brookfield is set to divest approximately 12% of its holdings in DexKo, an engineered components manufacturing operation. Additionally, it will sell about 7% of CDK Global, a leader in dealer software and technology services, as well as roughly 5% of BrandSafway, which specializes in work access services. This targeted divestment allows Brookfield Business Partners to channel resources into the new fund dedicated to high-net-worth investors.
Intrinsic Value in the Deal
With this transaction, Brookfield anticipates receiving units of the New Fund, boasting an initial redemption value of around $690 million. This amount represents an attractive 8.6% discount to the net asset value (NAV) of the interests sold, offering a significant incentive for future investment. After an 18-month period from the fund's initial closing, scheduled for later this year, these units are projected to be redeemable for cash at the same discount to the NAV at the time.
Independent Review Enhances Confidence
An independent committee of directors within Brookfield Business Partners conducted a thorough review of the transaction, reinforcing its commitment to corporate governance. Engaging a reputable financial advisor and legal counsel ensured a comprehensive assessment, culminating in a fairness opinion underscoring the transaction's alignment with the best interests of its shareholders.
Impact on Shareholder Value
Anuj Ranjan, CEO of Brookfield Business Partners, expressed his enthusiasm for the deal, noting its value creation for unitholders and shareholders alike. He emphasized that this strategic endeavor not only provides a diversified initial portfolio for the New Fund but also facilitates Brookfield's ongoing commitment to shareholder returns through buyback programs and invigorated capital reinvestment.
Execution Timeline
The completion of this asset-sale transaction is set for July 4, 2025, marking a pivotal moment for Brookfield Business Partners as it solidifies its footing in the evolving market landscape.
Ongoing Commitment to Excellence
Brookfield Business Partners maintains a robust focus on owning and operating high-quality businesses. The company’s diverse portfolio continues to benefit from competitive advantages, ensuring that its stakeholders enjoy ongoing opportunities for growth and profitability. With management overseeing approximately $1 trillion in assets, Brookfield exemplifies a leader in alternative asset management.
Investor and Media Relations
Interested parties looking for further information can connect with Alan Fleming from Investor Relations at +1 416 645 2736 or reach out via email at alan.fleming@brookfield.com. For media inquiries, contact Marie Fuller at +44 207 408 875 or at marie.fuller@brookfield.com.
Frequently Asked Questions
What does the transaction entail for Brookfield Business Partners?
The transaction involves Brookfield selling a partial interest in three businesses to support a new evergreen private equity strategy.
What is the expected financial value from the transaction?
Brookfield anticipates receiving approximately $690 million in units of the New Fund, which reflects an 8.6% discount to net asset value.
How is the fairness of the deal ensured?
An independent committee, alongside a financial advisor, assessed the transaction, providing a fairness opinion to validate its benefits for shareholders.
When is the expected completion date of the deal?
The transaction is anticipated to be finalized on July 4, 2025.
Who can interested investors contact for more information?
Investors can contact Alan Fleming for inquiries related to the company’s performance or the recent transaction.
